5 Stocks Pulling The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 14 points (0.1%) at 14,951 as of Friday, Sept. 6, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,968 issues advancing vs. 907 declining with 132 unchanged.

The Health Services industry currently sits up 0.1% versus the S&P 500, which is up 0.2%. A company within the industry that fell today was Emeritus Corporation ( ESC), up 8.6%. Top gainers within the industry include HCA Holdings ( HCA), up 2.3%, Grifols ( GRFS), up 1.5%, C.R. Bard ( BCR), up 0.9%, Express Scripts ( ESRX), up 0.9% and Zimmer Holdings ( ZMH), up 0.6%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Mindray Medical International ( MR) is one of the companies pushing the Health Services industry lower today. As of noon trading, Mindray Medical International is down $0.80 (-2.0%) to $39.97 on average volume. Thus far, 415,494 shares of Mindray Medical International exchanged hands as compared to its average daily volume of 706,500 shares. The stock has ranged in price between $39.64-$41.02 after having opened the day at $40.95 as compared to the previous trading day's close of $40.77.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International has a market cap of $4.6 billion and is part of the health care sector. Shares are up 24.7% year to date as of the close of trading on Thursday. Currently there are 4 analysts that rate Mindray Medical International a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Mindray Medical International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, impressive record of earnings per share growth and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Mindray Medical International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Cooper Companies ( COO) is down $3.94 (-3.0%) to $129.32 on heavy volume. Thus far, 388,387 shares of Cooper Companies exchanged hands as compared to its average daily volume of 253,700 shares. The stock has ranged in price between $126.79-$131.90 after having opened the day at $131.90 as compared to the previous trading day's close of $133.25.

The Cooper Companies, Inc. operates as a medical device company worldwide. Cooper Companies has a market cap of $6.5 billion and is part of the health care sector. Shares are up 44.1% year to date as of the close of trading on Thursday. Currently there are 7 analysts that rate Cooper Companies a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Cooper Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Cooper Companies Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Tenet Healthcare ( THC) is down $0.74 (-1.8%) to $39.94 on average volume. Thus far, 655,382 shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $39.64-$40.94 after having opened the day at $40.92 as compared to the previous trading day's close of $40.68.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Tenet Healthcare has a market cap of $4.0 billion and is part of the health care sector. Shares are up 25.3% year to date as of the close of trading on Thursday. Currently there are 7 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Tenet Healthcare Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Catamaran ( CTRX) is down $0.49 (-0.9%) to $55.60 on light volume. Thus far, 289,440 shares of Catamaran exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $55.15-$56.79 after having opened the day at $56.65 as compared to the previous trading day's close of $56.09.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $11.4 billion and is part of the health care sector. Shares are up 19.1% year to date as of the close of trading on Thursday. Currently there are 14 analysts that rate Catamaran a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, compelling growth in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Catamaran Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, DaVita HealthCare Partners ( DVA) is down $0.99 (-0.9%) to $110.56 on light volume. Thus far, 308,828 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 876,400 shares. The stock has ranged in price between $109.60-$111.74 after having opened the day at $111.44 as compared to the previous trading day's close of $111.55.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $11.6 billion and is part of the health care sector. Shares are up 0.9% year to date as of the close of trading on Thursday. Currently there are 7 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, increase in net income, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full DaVita HealthCare Partners Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

GE Confirms $11.1 Billion Transportation Merger With Wabtec

GE Confirms $11.1 Billion Transportation Merger With Wabtec